SUN-023 - Long-Term Safety and Efficacy of Once-Daily Oral Paltusotine in Combination with Cabergoline for the Treatment of Patients with Acromegaly

Co-Author(s)

• MG

  Monica R. Gadelha, MD, PhD

  Centro de Pesquisa Clínica, Instituto Estadual do Cérebro Paulo Niemeyer
  Rio de Janeiro, Brazil
• MG

  Murray B. Gordon, MD

  Allegheny Neuroendocrinology Center, Allegheny General Hospital
  Pittsburgh, United States
• MD

  Mirjana Doknic, MD

  Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade
  Belgrade, Serbia
• EM

  Emese Mezősi, MD, PhD, DSc

  Clinical Center, University of Pécs Medical School
  Pécs, Hungary
• MT

  Miklos Toth, MD, PhD, DSc

  Semmelweis University
  Budapest, Hungary
• HR

  Harpal Randeva, MBChB, FRCP, FAcad TM, PhD

  Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, and Division of Biomedicine, Warwick Medical School, University of Warwick
  Coventry, United Kingdom
• CB

  Cesar L. Boguszewski, MD, PhD

  Endocrine Division (SEMPR), University Hospital, Federal University of Paraná
  Curitiba, Brazil
• CD

  Christopher Davidson, MS

  Crinetics Pharmaceuticals, Inc.
  San Diego, United States

Abstract Poster Presenter(s)

• AC

  Alessandra Casagrande, MD, PhD

  Crinetics Pharmaceuticals, Inc.
  San Diego, California, United States

Co-Author(s)

• AC

  Alessandra Casagrande, MD, PhD

  Crinetics Pharmaceuticals, Inc.
  San Diego, California, United States
• TJ

  Theresa Jochelson, BSc

  Crinetics Pharmaceuticals, Inc.
  San Diego, United States